BR9809022A - Composições antiinflamatórias nasais tópicas - Google Patents

Composições antiinflamatórias nasais tópicas

Info

Publication number
BR9809022A
BR9809022A BR9809022-4A BR9809022A BR9809022A BR 9809022 A BR9809022 A BR 9809022A BR 9809022 A BR9809022 A BR 9809022A BR 9809022 A BR9809022 A BR 9809022A
Authority
BR
Brazil
Prior art keywords
nasal
agent
compositions
effective amount
therapeutically effective
Prior art date
Application number
BR9809022-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR9809022A publication Critical patent/BR9809022A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9809022-4A 1997-04-30 1998-04-02 Composições antiinflamatórias nasais tópicas BR9809022A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4430697P 1997-04-30 1997-04-30
PCT/US1998/006483 WO1998048839A1 (en) 1997-04-30 1998-04-02 Topical nasal antiinflammatory compositions

Publications (1)

Publication Number Publication Date
BR9809022A true BR9809022A (pt) 2000-08-01

Family

ID=21931638

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809022-4A BR9809022A (pt) 1997-04-30 1998-04-02 Composições antiinflamatórias nasais tópicas

Country Status (8)

Country Link
EP (1) EP0979105A1 (zh)
JP (1) JP2001524108A (zh)
CN (1) CN1253508A (zh)
AU (1) AU6878098A (zh)
BR (1) BR9809022A (zh)
CA (1) CA2281789A1 (zh)
IL (1) IL131492A0 (zh)
WO (1) WO1998048839A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000517T2 (tr) * 1997-08-26 2000-08-21 Hoechst Marion Roussel, Inc. Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
ATE331522T1 (de) * 1997-12-23 2006-07-15 Schering Corp Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
IT1313567B1 (it) * 1999-07-27 2002-09-09 Zambon Spa Uso della n-acetil-cisteina per la preparazione di composizionifarmaceutiche topiche per il trattamento di patologie allergiche delle
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
HU226527B1 (hu) * 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP2005533076A (ja) * 2002-06-20 2005-11-04 ノバルテイス・コンシユーマー・ヘルス・エス・アー ムコ多糖及びプロピレングリコールを含む鼻用組成物
ES2348034T3 (es) 2002-08-30 2010-11-29 Nycomed Gmbh Uso de la combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
WO2005013963A1 (en) * 2003-08-06 2005-02-17 Galephar M/F Advantageous combinations for inhalation of nacystelyn and bronchodilators
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
HUE030388T2 (en) 2004-11-24 2017-05-29 Meda Pharmaceuticals Inc Preparations and methods of use containing azelastine
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
AU2006224842B2 (en) * 2005-03-16 2011-09-29 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
CN102008460B (zh) * 2005-08-26 2012-09-19 株式会社明治 抗过敏剂
EP2851064A3 (en) * 2006-07-11 2015-08-05 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
JP2008143845A (ja) * 2006-12-11 2008-06-26 Hoshienu Seiyaku Kk 点鼻薬組成物及び点鼻薬液噴霧器具
BR112014029442A2 (pt) * 2012-05-25 2017-06-27 Xlear Inc composições antimucosas à base de xilitol e métodos e composições relacionados
CN104667256B (zh) * 2015-03-18 2017-05-03 江苏威克斯医疗科技有限公司 一种鼻腔粘膜纤毛护理冲洗液及其用途
CN107753485A (zh) * 2017-11-28 2018-03-06 赵永宏 一种兼有鼻减充血和麻醉作用的药物组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482015A (en) * 1965-02-08 1969-12-02 Merck & Co Inc Aerosol composition of phenylephrine tartrate and the production of such
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
JPH0753671B2 (ja) * 1985-12-26 1995-06-07 積水化学工業株式会社 経皮・経粘膜製剤
EP0661967B1 (en) * 1991-11-19 1999-08-25 University Of Virginia Patent Foundation Combined virustatic antimediator (covam) treatment of common colds
CN1130354A (zh) * 1993-09-07 1996-09-04 普罗克特和廿保尔公司 含有丙酸类非甾体消炎药氨基酸盐和减充血药、祛痰药、抗组胺药和镇咳药中至少一种的组合物
WO1997001337A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
WO1997001341A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
DE19532714A1 (de) * 1995-09-05 1997-03-06 Bayer Ag Kombination von 5-Lipoxygenase- und Leukotriensynthese Inhibitoren mit Glucocorticosteroiden
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine

Also Published As

Publication number Publication date
IL131492A0 (en) 2001-01-28
WO1998048839A1 (en) 1998-11-05
EP0979105A1 (en) 2000-02-16
CN1253508A (zh) 2000-05-17
AU6878098A (en) 1998-11-24
CA2281789A1 (en) 1998-11-05
JP2001524108A (ja) 2001-11-27

Similar Documents

Publication Publication Date Title
BR9809022A (pt) Composições antiinflamatórias nasais tópicas
BR9916746A (pt) Compostos anti-inflamatórios que inibem adesão de célula
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
DK0650483T3 (da) (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
UY25322A1 (es) Compuestos de tiourea y benzamida,composiciones y metodos para tratar y prevenir enfermedades inflamatorias y aterosclerosis
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
NO20004736D0 (no) Xylitolblandinger for behandling av øvre respiratoriske tilstander
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
BR0010562A (pt) Inibidor de metaloprotease do ácido hidrox mico de sulfona aromática
BR9811099A (pt) Inibidores de urocinase
BRPI0417158A (pt) composto, composição farmacêutica, uso de um composto, método para prevenir, tratar ou melhorar uma doença ou condição associada com angiogênese desregulada, e, métodos para tratar ou melhorar cáncer, para reduzir o potencial metastático de um tumor, e para tratar ou melhorar tumores, e uma condição ou doença
ES2184960T3 (es) Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas.
BR9914158A (pt) Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
DK0912185T3 (da) Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
BR0010546A (pt) Terapia antiinflamatória para infecção mediada inflamatória
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
BR9712705A (pt) Composição para o tratamento da asma, contendo loratadina e um descongestionante
BR9713207A (pt) Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz
SE9801494D0 (sv) Novel use
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/57 (2006.01), A61K 31/58 (2006.0